Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Archaeosomes as novel antigen delivery systems

G D Sprott1, D L Tolson, G B Patel

  • 1Institute for Biological Sciences, National Research Council of Canada, Ottawa, Ont., Canada. dennis.sprott@nrc.ca

FEMS Microbiology Letters
|September 23, 1997
PubMed
Summary

Archaeosomes, lipid vesicles from archaea, significantly enhance immune responses in mice compared to conventional liposomes. These novel carriers efficiently boost antibody production with fewer immunizations, showing promise for vaccine development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibition of airway eosinophilia and pulmonary pathology in a mouse model of allergic asthma by the live vaccine strain of Francisella tularensis.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2008
Same author

Liposome adjuvants prepared from the total polar lipids of Haloferax volcanii, Planococcus spp. and Bacillus firmus differ in ability to elicit and sustain immune responses.

Vaccine·2004
Same author

Novel polar lipids of halophilic eubacterium Planococcus H8 and archaeon Haloferax volcanii.

Biochimica et biophysica acta·2003
Same author

HIV type 1 vaccine-induced T cell memory and cytotoxic T lymphocyte responses in HIV type 1-uninfected volunteers.

AIDS research and human retroviruses·2001
Same author

Molecular mechanisms of water and solute transport across archaebacterial lipid membranes.

The Journal of biological chemistry·2001
Same author

Immunization of mice with lipopeptide antigens encapsulated in novel liposomes prepared from the polar lipids of various Archaeobacteria elicits rapid and prolonged specific protective immunity against infection with the facultative intracellular pathogen, Listeria monocytogenes.

Vaccine·2001

Area of Science:

  • Immunology
  • Biochemistry
  • Biotechnology

Background:

  • Liposomes are widely used drug and antigen delivery systems.
  • Archaeal ether lipids offer unique structural properties compared to conventional lipids.
  • The in vivo immunogenicity of archaeal lipid-based vesicles (archaeosomes) as antigen carriers is largely unexplored.

Purpose of the Study:

  • To compare the immunogenicity of antigens delivered via archaeosomes versus conventional liposomes.
  • To evaluate the efficacy of archaeosomes as antigen carriers for enhancing humoral immune responses.
  • To investigate the influence of different archaeosome compositions on immune potentiation.

Main Methods:

  • BALB/c mice were immunized intraperitoneally with bovine serum albumin or cholera toxin B subunit encapsulated in various archaeosomes and conventional liposomes.

Related Experiment Videos

  • Antibody titers in sera were measured to assess the humoral immune response.
  • Different archaeosome compositions, including those from Methanobrevibacter smithii, were tested.

    • Main Results:

    • Archaeosomes significantly potentiated antibody responses, comparable or superior to Freund's adjuvant.
    • Fewer immunizations (at most two) were required to achieve high antibody titers with archaeosomes.
    • Antigen encapsulation within archaeosomes was crucial for eliciting a full humoral response.
    • Methanobrevibacter smithii archaeosomes demonstrated strong immunopotentiation for both tested antigens.

    Conclusions:

    • Archaeosomes are highly effective antigen carriers for enhancing humoral immunity in vivo.
    • Archaeosomes represent a promising platform for developing novel vaccine formulations.
    • This study provides the first in vivo evaluation of archaeosomes as antigen carriers.